Geoffrey L. Greene, PhD - Publications

Affiliations: 
Ben May Department for Cancer Research University of Chicago, Chicago, IL 
Area:
breast cancer, steroid hormone action
Website:
http://benmay.uchicago.edu/faculty/greene

147 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mayne CG, Toy W, Carlson KE, Bhatt T, Fanning SW, Greene GL, Katzenellenbogen BS, Chandarlapaty S, Katzenellenbogen JA, Tajkhorshid E. Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer. Molecular Cancer Research : McR. PMID 34021071 DOI: 10.1158/1541-7786.MCR-20-1017  0.359
2021 Lainé M, Fanning SW, Chang YF, Green B, Greene ME, Komm B, Kurleto JD, Phung L, Greene GL. Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Breast Cancer Research : Bcr. 23: 54. PMID 33980285 DOI: 10.1186/s13058-021-01431-w  0.316
2020 Abderrahman B, Maximov PY, Curpan RF, Fanning SW, Hanspal JS, Fan P, Foulds CE, Chen Y, Malovannaya A, Jain A, Xiong R, Greene GL, Tonetti DA, Thatcher GRJ, Jordan VC. Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer. Molecular Cancer Therapeutics. PMID 33177154 DOI: 10.1158/1535-7163.MCT-20-0563  0.316
2020 Maximov PY, Abderrahman B, Hawsawi YM, Chen Y, Foulds CE, Jain A, Malovannaya A, Fan P, Curpan RF, Han R, Fanning SW, Broom BM, Quintana Rincon DM, Greenland JA, Greene GL, et al. The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. Molecular Pharmacology. PMID 32362585 DOI: 10.1124/Mol.120.119776  0.443
2020 Kastrati I, Joosten SEP, Semina SE, Alejo LH, Brovkovych SD, Stender JD, Horlings HM, Kok M, Alarid ET, Greene GL, Linn SC, Zwart W, Frasor J. The NFκB pathway promotes tamoxifen tolerance and disease recurrence in estrogen receptor positive breast cancers. Molecular Cancer Research : McR. PMID 32245803 DOI: 10.1158/1541-7786.Mcr-19-1082  0.417
2020 Fanning SW, Greene G, Conlan MG. X-ray crystal structure analysis of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), bound to estrogen receptor alpha ligand binding domain. Journal of Clinical Oncology. 38: e15647-e15647. DOI: 10.1200/Jco.2020.38.15_Suppl.E15647  0.47
2020 Ren P, Fanning SW, Tiede C, Adams TL, Speirs V, Greene GL, Nelson ER, Tomlinson DC, Selvin PR. Efficient Labeling of Estrogen Receptor α Inside Cells using Affimer, an Antibody Mimetic Biophysical Journal. 118: 470a. DOI: 10.1016/J.Bpj.2019.11.2607  0.337
2019 Cocce KJ, Jasper JS, Desautels TK, Everett L, Wardell S, Westerling T, Baldi R, Wright TM, Tavares K, Yllanes A, Bae Y, Blitzer JT, Logsdon C, Rakiec DP, Ruddy DA, ... ... Greene GL, et al. The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Reports. 29: 889-903.e10. PMID 31644911 DOI: 10.1016/J.Celrep.2019.09.032  0.38
2019 Fanning SW, Greene GL. Next Generation ERα Inhibitors for Endocrine-Resistant ER+ Breast Cancers. Endocrinology. PMID 30753408 DOI: 10.1210/En.2018-01095  0.405
2019 Fanning S, Laine M, Greene M, Chang Y, Phung L, Green B, Hiipakka R, Han R, Komm B, Greene G. SUN-006 Lasofoxifene Achieves Potent Anti-Tumor Activity in Hormone-Resistant Breast Tumors by Maintaining High Affinity Binding for Y537S ERα Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sun-006  0.36
2019 Laine M, Fanning SW, Greene M, Chang Y, Phung L, Tan TT, Hiipakka R, Komm B, Greene G. Lasofoxifene as a potential treatment for ER+ metastatic breast cancer. Journal of Clinical Oncology. 37: 1056-1056. DOI: 10.1200/Jco.2019.37.15_Suppl.1056  0.377
2019 Bueter E, Hosfield D, McAuley E, Selman P, Greene G, Conzen SD, Szmulewitz RZ. Abstract 1016: The androgen receptor splice variant AR-V7 associates with the glucocorticoid receptor following androgen blockade Cancer Research. 79: 1016-1016. DOI: 10.1158/1538-7445.Am2019-1016  0.394
2018 Fanning SW, Jeselsohn R, Dharmarajan V, Mayne CG, Karimi M, Buchwalter G, Houtman R, Toy W, Fowler CE, Han R, Lainé M, Carlson KE, Martin TA, Nowak J, Nwachukwu JC, ... ... Greene GL, et al. The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells. Elife. 7. PMID 30489256 DOI: 10.7554/Elife.37161  0.718
2018 Sharma A, Toy W, Guillen VS, Sharma N, Min J, Carlson KE, Mayne CG, Lin S, Sabio M, Greene G, Katzenellenbogen BS, Chandarlapaty S, Katzenellenbogen JA. Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain. Acs Chemical Biology. PMID 30404440 DOI: 10.1021/Acschembio.8B00877  0.467
2018 Katzenellenbogen JA, Mayne CG, Katzenellenbogen BS, Greene GL, Chandarlapaty S. Publisher Correction: Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nature Reviews. Cancer. PMID 30185950 DOI: 10.1038/S41568-018-0053-0  0.333
2018 Fanning SW, Hodges-Gallagher L, Myles DC, Sun R, Fowler CE, Plant IN, Green BD, Harmon CL, Greene GL, Kushner PJ. Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity. Nature Communications. 9: 2368. PMID 29915250 DOI: 10.1038/S41467-018-04413-3  0.442
2018 Maximov PY, Abderrahman B, Fanning SW, Sengupta S, Fan P, Curpan RF, Quintana Rincon DM, Greenland JA, Rajan SS, Greene GL, Jordan VC. Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Molecular Pharmacology. PMID 29739819 DOI: 10.1124/Mol.117.111385  0.445
2018 Katzenellenbogen JA, Mayne CG, Katzenellenbogen BS, Greene GL, Chandarlapaty S. Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nature Reviews. Cancer. PMID 29662238 DOI: 10.1038/S41568-018-0001-Z  0.472
2018 West DC, Kocherginsky M, Tonsing-Carter EY, Dolcen DN, Hosfield DJ, Lastra RR, Sinnwell JP, Thompson KJ, Bowie KR, Harkless RV, Skor MN, Pierce CF, Styke SC, Kim CR, de Wet L, ... Greene GL, et al. Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29636357 DOI: 10.1158/1078-0432.Ccr-17-2793  0.435
2018 Singhal H, Greene ME, Zarnke AL, Laine M, Al Abosy R, Chang YF, Dembo AG, Schoenfelt K, Vadhi R, Qiu X, Rao P, Santhamma B, Nair HB, Nickisch KJ, Long HW, ... ... Greene GL, et al. Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling. Oncotarget. 9: 4282-4300. PMID 29435103 DOI: 10.18632/Oncotarget.21378  0.469
2018 Fanning SW, Jeselsohn R, Dharmarajan V, Mayne CG, Karimi M, Buchwalter G, Houtman R, Toy W, Fowler CE, Han R, Lainé M, Carlson KE, Martin TA, Nowak J, Nwachukwu JC, ... ... Greene GL, et al. Author response: The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells Elife. DOI: 10.7554/Elife.37161.024  0.68
2018 Speltz TE, Danes JM, Fanning SW, Mayne CG, Tajkhorshid E, Greene GL, Frasor JM, Moore TW. Abstract 1810: Stapled peptide inhibitors of mutant estrogen receptor/coactivator interactions Cancer Research. 78: 1810-1810. DOI: 10.1158/1538-7445.Am2018-1810  0.451
2017 Walter K, Goodman ML, Singhal H, Hall J, Li T, Holloran S, Trinca G, Gibson K, Jin VX, Greene G, Hagan C. Interferon-Stimulated Genes are Transcriptionally Repressed by PR in Breast Cancer. Molecular Cancer Research : McR. PMID 28684637 DOI: 10.1158/1541-7786.Mcr-17-0180  0.418
2017 Abderrahman B, Fanning SW, Rincon DQ, Greene G, Maximov PY, Jordan VC. Abstract 5633: Unique modulation of estrogen-induced apoptosis with structural analogues of endoxifen in long-term estrogen-deprived (LTED) breast cancer cells Cancer Research. 77: 5633-5633. DOI: 10.1158/1538-7445.Am2017-5633  0.381
2016 Singhal H, Greene ME, Tarulli G, Zarnke AL, Bourgo RJ, Laine M, Chang YF, Ma S, Dembo AG, Raj GV, Hickey TE, Tilley WD, Greene GL. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Science Advances. 2: e1501924. PMID 27386569 DOI: 10.1126/Sciadv.1501924  0.467
2016 Fanning SW, Mayne CG, Dharmarajan V, Carlson KE, Martin TA, Novick SJ, Toy W, Green B, Panchamukhi S, Katzenellenbogen BS, Tajkhorshid E, Griffin PR, Shen Y, Chandarlapaty S, Katzenellenbogen JA, ... Greene GL, et al. Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation. Elife. 5. PMID 26836308 DOI: 10.7554/Elife.12792  0.414
2016 West D, Hosfield D, Mayne C, Skor M, Styke S, Pierce C, Kocherginsky M, Hunt H, Fleming G, Szmulewitz R, Tajkhorshid E, Greene G, Conzen S. Abstract PD3-02: Second-generation selective glucocorticoid receptor modulators in triple-negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Pd3-02  0.457
2016 Maximov P, Sengupta S, Fernandes D, Fan P, Curpan R, Rajan S, Greene G, Jordan V. Abstract P3-05-11: The evolution of the estrogen receptor (ER) complex conformation governs estrogen-induced apoptosis in antihormone-resistant breast cancer cells Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-05-11  0.44
2016 Fanning SW, Dharmarajan V, Mayne CG, Toy W, Carlson KE, Martin TA, Nowak J, Nwachukwu J, Hosfield DJ, Tajkhorshid E, Chandarlapaty S, Griffin P, Shen Y, Katzenellenbogen JA, Greene GL. Abstract 4854: Bazedoxifene inhibits ESR1 somatic mutants with improved potency compared to tamoxifene and raloxifene Cancer Research. 76: 4854-4854. DOI: 10.1158/1538-7445.Am2016-4854  0.427
2016 Moore TW, Speltz TE, Fanning SW, Mayne CG, Frasor J, Greene GL, Tajkhorshid E. Abstract 3104: Stapled peptide inhibitors of the estrogen receptor/steroid receptor coactivator interaction Cancer Research. 76: 3104-3104. DOI: 10.1158/1538-7445.Am2016-3104  0.435
2016 Speltz TE, Fanning SW, Mayne CG, Fowler C, Tajkhorshid E, Greene GL, Moore TW. Inside Cover: Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction (Angew. Chem. Int. Ed. 13/2016) Angewandte Chemie International Edition. 55: 4104-4104. DOI: 10.1002/Anie.201601641  0.319
2016 Speltz TE, Fanning SW, Mayne CG, Fowler C, Tajkhorshid E, Greene GL, Moore TW. Innentitelbild: Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction (Angew. Chem. 13/2016) Angewandte Chemie. 128: 4174-4174. DOI: 10.1002/Ange.201601641  0.321
2015 Singhal H, Greene G. Relationship of progestin receptor to estrogen receptor and the relevance of the progestin receptor in predicting survival in breast cancer. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E11514  0.474
2015 Fanning SW, Mayne C, Toy W, Shen Y, Sharma A, Panchamukhi S, Nowak J, Nettles KW, Chandarlapaty S, Katzenellenbogen JA, Greene GL. Abstract P3-05-07: Determining the role of somatic ERα mutations in acquired hormone (or SERM) resistance Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-05-07  0.445
2014 Abot A, Fontaine C, Buscato M, Solinhac R, Flouriot G, Fabre A, Drougard A, Rajan S, Laine M, Milon A, Muller I, Henrion D, Adlanmerini M, Valéra MC, Gompel A, ... ... Greene GL, et al. The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. Embo Molecular Medicine. 6: 1328-46. PMID 25214462 DOI: 10.15252/Emmm.201404112  0.381
2014 Singhal H, Greene G. Abstract 5571: Genome-wide crosstalk of estrogen and progesterone signaling in breast cancer Cancer Research. 74: 5571-5571. DOI: 10.1158/1538-7445.Am2014-5571  0.441
2014 Fontaine C, Abot A, Solinhac R, Drougard A, Fabre A, Buscato M, Milon A, Rajan S, Laine M, Henrion D, Mestdagt M, Raymond-Letron I, Flouriot G, Knauf C, Katzenellenbogen BS, ... ... Greene GL, et al. 0218: The uterine and vascular actions of estetrol delineate an original distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation Archives of Cardiovascular Diseases Supplements. 6: 8. DOI: 10.1016/S1878-6480(14)71283-2  0.353
2013 Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA, Hudis C, Chen D, Taran T, Hortobagyi G, Greene G, et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nature Genetics. 45: 1439-45. PMID 24185512 DOI: 10.1038/Ng.2822  0.445
2013 O'Leary KA, Jallow F, Rugowski DE, Sullivan R, Sinkevicius KW, Greene GL, Schuler LA. Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo. Endocrinology. 154: 4483-92. PMID 24064365 DOI: 10.1210/En.2013-1533  0.813
2013 Le TP, Sun M, Luo X, Kraus WL, Greene GL. Mapping ERβ Genomic Binding Sites Reveals Unique Genomic Features and Identifies EBF1 as an ERβ Interactor Plos One. 8. PMID 23951143 DOI: 10.1371/Journal.Pone.0071355  0.614
2013 Huang W, Greene GL, Ravikumar KM, Yang S. Cross-talk between the ligand- and DNA-binding domains of estrogen receptor Proteins: Structure, Function and Bioinformatics. 81: 1900-1909. PMID 23737157 DOI: 10.1002/Prot.24331  0.363
2013 Balbas MD, Evans MJ, Hosfield DJ, Wongvipat J, Arora VK, Watson PA, Chen Y, Greene GL, Shen Y, Sawyers CL. Overcoming mutation-based resistance to antiandrogens with rational drug design. Elife. 2: e00499. PMID 23580326 DOI: 10.7554/Elife.00499  0.302
2013 Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang YF, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Young Park S, Eileen Dolan M, Perou CM, ... ... Greene GL, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 Nature Communications. 4. PMID 23340433 DOI: 10.1038/Ncomms2393  0.716
2013 Bockhorn J, Yee K, Chang YF, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Breast Cancer Research and Treatment. 137: 373-382. PMID 23224145 DOI: 10.1007/S10549-012-2346-4  0.713
2013 Greene GL. In Memoriam: Elwood Jensen (1920–2012) Molecular Endocrinology. 27: 1589-1591. DOI: 10.1210/Me.2013-1248  0.41
2013 Liu H, Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang Y, Huo D, Lu J, Dolan E, Perou CM, Olopade OI, Clarke MF, Greene G. Abstract 832: MicroRNA-30c inhibits human breast tumor chemo-resistance by regulating twinfinlin-1 (TWF1) and IL-11. Cancer Research. 73: 832-832. DOI: 10.1158/1538-7445.Am2013-832  0.709
2013 Bockhorn J, Yee K, Chang Y, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olufunmilayo OI, Clarke MF, Liu H, Greene G. Abstract 5337: MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Cancer Research. 73: 5337-5337. DOI: 10.1158/1538-7445.Am2013-5337  0.714
2012 Romero IL, Lee W, Mitra AK, Gordon IO, Zhao Y, Leonhardt P, Penicka CV, Mui KL, Krausz TN, Greene GL, Lengyel E. The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis Gynecologic Oncology. 124: 134-141. PMID 21996264 DOI: 10.1016/J.Ygyno.2011.08.026  0.394
2012 Huang S, Yee K, Bockhorn J, Kim S, Huo D, Olopade O, Liu H, Greene G. Abstract 4198: Transcriptional regulation of breast cancer microRNAs by GATA3 and TFAP2A Cancer Research. 72: 4198-4198. DOI: 10.1158/1538-7445.Am2012-4198  0.705
2012 Liu H, Bockhorn J, Dalton R, Nwachukwu C, Prat A, Yee K, Huang S, Swanson K, Perou CM, Olopade OI, Clarke MF, Greene GL. Abstract 3331: MicroRNAs regulate breast cancer stem cells and spontaneous metastases in orthotopic xenograft models Cancer Research. 72: 3331-3331. DOI: 10.1158/1538-7445.Am2012-3331  0.702
2011 Liu H, Bockhorn J, Dalton R, Dolan ME, Perou CM, Olopade OI, Clarke MF, Greene G. Roles of miRNAs in breast cancer stem cells, drug sensitivity, and spontaneous metastases in orthotopic human-in-mouse models. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1082. PMID 28021259 DOI: 10.1200/Jco.2011.29.15_Suppl.1082  0.336
2011 Liu H, Bockhorn J, Dalton R, Chang YF, Qian D, Zitzow LA, Clarke MF, Greene GL. Removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sorting Journal of Virological Methods. 173: 266-270. PMID 21354210 DOI: 10.1016/J.Jviromet.2011.02.015  0.68
2011 Walker MP, Zhang M, Le TP, Wu P, Lainé M, Greene GL. RAC3 is a pro-migratory co-activator of ERα. Oncogene. 30: 1984-94. PMID 21217774 DOI: 10.1038/Onc.2010.583  0.644
2011 Liu H, Bockhorn J, Dalton R, Olopade OF, Clarke MF, Greene GL. Abstract 1582: Identification of miRNAs that regulate breast cancer stem cells and spontaneous metastases in orthotopic mouse models Cancer Research. 71: 1582-1582. DOI: 10.1158/1538-7445.Am2011-1582  0.701
2011 Bockhorn J, Chang Y, Liu H, Greene G. Abstract 1431: An optimized in vitro method to evaluate primary tumor cell invasion using optical imaging technology Cancer Research. 71: 1431-1431. DOI: 10.1158/1538-7445.Am2011-1431  0.656
2010 Romero IL, Lee W, Mui K, Leonhardt P, Penicka C, Greene GL, Lengyel E. Abstract A103: The effect of 17β-estradiol on ovarian carcinogenesis in vitro and in a genetic mouse model Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-A103  0.378
2009 Sinkevicius KW, Woloszyn K, Laine M, Jackson KS, Greene GL, Woodruff TK, Burdette JE. Characterization of the ovarian and reproductive abnormalities in prepubertal and adult estrogen non-responsive estrogen receptor α knock-in (ENERKI) mice Steroids. 74: 913-919. PMID 19631674 DOI: 10.1016/J.Steroids.2009.06.012  0.801
2009 Sinkevicius KW, Laine M, Lotan TL, Woloszyn K, Richburg JH, Greene GL. Estrogen-dependent and -independent estrogen receptor-α signaling separately regulate male fertility Endocrinology. 150: 2898-2905. PMID 19264877 DOI: 10.1210/En.2008-1016  0.803
2009 Haiman CA, Garcia RR, Hsu C, Xia L, Ha H, Sheng X, Le Marchand L, Kolonel LN, Henderson BE, Stallcup MR, Greene GL, Press MF. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: The Multiethnic Cohort Bmc Cancer. 9. PMID 19183483 DOI: 10.1186/1471-2407-9-43  0.38
2009 Leong H, Mathur PS, Greene GL. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation Breast Cancer Research and Treatment. 117: 505-515. PMID 18821062 DOI: 10.1007/S10549-008-0196-X  0.31
2008 O'Neill EE, Blewett AR, Loria PM, Greene GL. Modulation of alphaCaMKII signaling by rapid ERalpha action. Brain Research. 1222: 1-17. PMID 18572149 DOI: 10.1016/J.Brainres.2008.05.036  0.672
2008 Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB, Kulp K, Hochberg RB, Zhou H, Katzenellenbogen JA, Katzenellenbogen BS, Kim Y, Joachmiak A, Greene GL. NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nature Chemical Biology. 4: 241-7. PMID 18344977 DOI: 10.1038/Nchembio.76  0.712
2008 Sinkevicius KW, Burdette JE, Woloszyn K, Hewitt SC, Hamilton K, Sugg SL, Temple KA, Wondisford FE, Korach KS, Woodruff TK, Greene GL. An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology. 149: 2970-9. PMID 18339713 DOI: 10.1210/En.2007-1526  0.804
2008 Hsieh RW, Rajan SS, Sharma SK, Greene GL. Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of Premarin Steroids. 73: 59-68. PMID 17949766 DOI: 10.1016/J.Steroids.2007.08.014  0.798
2008 Nettles KW, Gil G, Nowak J, Métivier R, Sharma VB, Greene GL. CBP is a dosage-dependent regulator of nuclear factor-κB suppression by the estrogen receptor Molecular Endocrinology. 22: 263-272. PMID 17932106 DOI: 10.1210/Me.2007-0324  0.697
2008 Leong H, Mathur PS, Greene GL. Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea Breast Cancer Research and Treatment. 107: 359-369. PMID 17484049 DOI: 10.1007/S10549-007-9568-X  0.329
2008 Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB, Kulp K, Hochberg RB, Zhou H, Katzenellenbogen JA, Katzenellenbogen BS, Kim Y, Joachimiak A, Greene GL. Corrigendum: NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses (Nature Chemical Biology (2008) 4, (241-247)) Nature Chemical Biology. 4: 379. DOI: 10.1038/Nchembio0608-379B  0.707
2007 Zhou HB, Nettles KW, Bruning JB, Kim Y, Joachimiak A, Sharma S, Carlson KE, Stossi F, Katzenellenbogen BS, Greene GL, Katzenellenbogen JA. Elemental Isomerism: A Boron-Nitrogen Surrogate for a Carbon-Carbon Double Bond Increases the Chemical Diversity of Estrogen Receptor Ligands Chemistry and Biology. 14: 659-669. PMID 17584613 DOI: 10.1016/J.Chembiol.2007.04.009  0.691
2007 Nettles KW, Bruning JB, Gil G, O'Neill EE, Nowak J, Hughs A, Kim Y, DeSombre ER, Dilis R, Hanson RN, Joachimiak A, Greene GL. Structural plasticity in the oestrogen receptor ligand-binding domain Embo Reports. 8: 563-568. PMID 17468738 DOI: 10.1038/Sj.Embor.7400963  0.79
2007 Zhou HB, Sheng S, Compton DR, Kim Y, Joachimiak A, Sharma S, Carlson KE, Katzenellenbogen BS, Nettles KW, Greene GL, Katzenellenbogen JA. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. Journal of Medicinal Chemistry. 50: 399-403. PMID 17228884 DOI: 10.1021/Jm061035Y  0.713
2006 Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, Mrksich M, Greene GL. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity Journal of Biological Chemistry. 281: 17909-17919. PMID 16648639 DOI: 10.1074/Jbc.M513684200  0.807
2006 Huang J, Koide A, Nettle KW, Greene GL, Koide S. Conformation-specific affinity purification of proteins using engineered binding proteins: Application to the estrogen receptor Protein Expression and Purification. 47: 348-354. PMID 16325424 DOI: 10.1016/J.Pep.2005.10.021  0.349
2005 Yeo WS, Min DH, Hsieh RW, Greene GL, Mrksich M. Label-free detection of protein-protein interactions on biochips Angewandte Chemie - International Edition. 44: 5480-5483. PMID 16052641 DOI: 10.1002/Anie.200501363  0.759
2005 Leong H, Sloan JR, Nash PD, Greene GL. Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor α Molecular Endocrinology. 19: 2930-2942. PMID 16051668 DOI: 10.1210/Me.2005-0178  0.386
2005 Wu YL, Yang X, Ren Z, McDonnell DP, Norris JD, Willson TM, Greene GL. Structural basis for an unexpected mode of SERM-Mediated ER antagonism Molecular Cell. 18: 413-424. PMID 15893725 DOI: 10.1016/J.Molcel.2005.04.014  0.562
2005 Nettles KW, Greene GL. Ligand control of coregulator recruitment to nuclear receptors Annual Review of Physiology. 67: 309-333. PMID 15709961 DOI: 10.1146/Annurev.Physiol.66.032802.154710  0.702
2004 Greene GL, Shiau AK, Nettles KW. A structural explanation for ERalpha/ERbeta SERM discrimination. Ernst Schering Research Foundation Workshop. 33-45. PMID 15248503 DOI: 10.1007/978-3-662-05386-7_3  0.666
2004 Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, Katzenellenbogen JA, Katzenellenbogen BS, Greene GL. Allosteric Control of Ligand Selectivity between Estrogen Receptors α and β: Implications for Other Nuclear Receptors Molecular Cell. 13: 317-327. PMID 14967140 DOI: 10.1016/S1097-2765(04)00054-1  0.713
2003 Nettles KW, Greene GL. Nuclear receptor ligands and cofactor recruitment: Is there a coactivator "On Deck"? Molecular Cell. 11: 850-851. PMID 12718871 DOI: 10.1016/S1097-2765(03)00133-3  0.693
2002 Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nature Structural Biology. 9: 359-64. PMID 11953755 DOI: 10.1038/Nsb787  0.697
2001 Griffin C, Flouriot G, Sharp P, Greene G, Gannon F. Distribution Analysis of the Two Chicken Estrogen Receptor-Alpha Isoforms and Their Transcripts in the Hypothalamus and Anterior Pituitary Gland Biology of Reproduction. 65: 1156-1163. PMID 11566738 DOI: 10.1095/Biolreprod65.4.1156  0.364
2000 Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P. Estrogen receptor pathways to AP-1. The Journal of Steroid Biochemistry and Molecular Biology. 74: 311-7. PMID 11162939 DOI: 10.1016/S0960-0760(00)00108-4  0.432
2000 Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, Webb P, Greene G. Oestrogen receptor function at classical and alternative response elements Novartis Foundation Symposium. 230: 20-32. PMID 10965500 DOI: 10.1002/0470870818.Ch3  0.396
1999 Lopez GN, Webb P, Shinsako JH, Baxter JD, Greene GL, Kushner PJ. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators Molecular Endocrinology. 13: 897-909. PMID 10379889 DOI: 10.1210/Mend.13.6.0283  0.449
1998 Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95: 927-37. PMID 9875847 DOI: 10.1016/S0092-8674(00)81717-1  0.39
1998 Wood JR, Greene GL, Nardulli AM. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Molecular and Cellular Biology. 18: 1927-34. PMID 9528764 DOI: 10.1128/Mcb.18.4.1927  0.413
1997 Greene ME, Blumberg B, Kwan K, Hsieh L, Greene GL, Nimer SD. Isolation and cloning of human peroxisome proliferator activated receptor gamma cDNA. Advances in Experimental Medicine and Biology. 400: 253-60. PMID 9547566 DOI: 10.1007/978-1-4615-5325-0_37  0.404
1997 Landel CC, Potthoff SJ, Nardulli AM, Kushner PJ, Greene GL. Estrogen receptor accessory proteins augment receptor-DNA interaction and DNA bending. The Journal of Steroid Biochemistry and Molecular Biology. 63: 59-73. PMID 9449207 DOI: 10.1016/S0960-0760(97)00073-3  0.377
1997 Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389: 753-8. PMID 9338790 DOI: 10.1038/39645  0.447
1997 Hess RA, Gist DH, Bunick D, Lubahn DB, Farrell A, Bahr J, Cooke PS, Greene GL. Estrogen Receptor (α and β) Expression in the Excurrent Ducts of the Adult Male Rat Reproductive Tract Journal of Andrology. 18: 602-611. DOI: 10.1002/J.1939-4640.1997.Tb02437.X  0.38
1996 Desombre ER, Hughes A, Landel CC, Greene G, Hanson R, Schwartz JL. Cellular And Subcellular Studies Of The Radiation Effects Of Auger Electron-Emitting Estrogens Acta Oncologica. 35: 833-840. PMID 9004760 DOI: 10.3109/02841869609104034  0.355
1996 Pertschuk LP, Masood S, Simone J, Feldman JG, Fruchter RG, Axiotis CA, Greene GL. Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecologic Oncology. 63: 28-33. PMID 8898164 DOI: 10.1006/Gyno.1996.0273  0.364
1996 Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, Kleinman HK, Greene GL, Schnaper HW. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 94: 1402-7. PMID 8822999 DOI: 10.1161/01.Cir.94.6.1402  0.341
1996 Nardulli AM, Romine LE, Carpo C, Greene GL, Rainish B. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Molecular Endocrinology (Baltimore, Md.). 10: 694-704. PMID 8776729 DOI: 10.1210/Mend.10.6.8776729  0.391
1995 Landel CC, Kushner PJ, Greene GL. Estrogen receptor accessory proteins: effects on receptor-DNA interactions. Environmental Health Perspectives. 103: 23-8. PMID 8593869 DOI: 10.1289/Ehp.95103S723  0.383
1995 Seielstad DA, Carlson KE, Katzenellenbogen JA, Kushner PJ, Greene GL. Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli. Molecular Endocrinology (Baltimore, Md.). 9: 647-58. PMID 8592511 DOI: 10.1210/Mend.9.6.8592511  0.351
1995 Seielstad DA, Carlson KE, Kushner PJ, Greene GL, Katzenellenbogen JA. Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. Biochemistry. 34: 12605-15. PMID 7548010 DOI: 10.1021/Bi00039A016  0.371
1994 Landel CC, Kushner PJ, Greene GL. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Molecular Endocrinology (Baltimore, Md.). 8: 1407-19. PMID 7854357 DOI: 10.1210/Mend.8.10.7854357  0.366
1993 Nardulli AM, Greene GL, Shapiro DJ. Human estrogen receptor bound to an estrogen response element bends DNA. Molecular Endocrinology (Baltimore, Md.). 7: 331-40. PMID 8483477 DOI: 10.1210/Mend.7.3.8483477  0.381
1993 Tucker MS, Khan I, Fuchs-Young R, Price S, Steininger TL, Greene G, Wainer BH, Rosner MR. Localization of immunoreactive epidermal growth factor receptor in neonatal and adult rat hippocampus. Brain Research. 631: 65-71. PMID 8298997 DOI: 10.1016/0006-8993(93)91187-W  0.325
1993 Fuqua SA, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Research and Treatment. 26: 191-202. PMID 8219256 DOI: 10.1007/Bf00689692  0.434
1992 Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Research. 52: 483-6. PMID 1728420  0.344
1992 Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ. The limits of the cellular capacity to mediate an estrogen response. Molecular Endocrinology (Baltimore, Md.). 6: 157-67. PMID 1569962 DOI: 10.1210/Mend.6.2.1569962  0.409
1992 Bettuzzi S, Robinson A, Fuchs-Young R, Greene GL. Estrogen and progesterone receptor structure and action in breast cancer cells. Cancer Treatment and Research. 61: 301-15. PMID 1360239 DOI: 10.1007/978-1-4615-3500-3_15  0.47
1992 Beckmann MW, Toney LJ, Scharl A, Fuchs-Young R, Greene GL, Holt JA. Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays. European Journal of Cancer (Oxford, England : 1990). 28: 322-6. PMID 1350453 DOI: 10.1016/S0959-8049(05)80046-2  0.388
1991 Ozzello L, DeRosa C, Habif DV, Greene GL. An immunohistochemical evaluation of progesterone receptor in frozen sections, paraffin sections, and cytologic imprints of breast carcinomas. Cancer. 67: 455-62. PMID 1845948 DOI: 10.1002/1097-0142(19910115)67:2<455::Aid-Cncr2820670223>3.0.Co;2-M  0.356
1991 Fuqua SA, Hill SM, Chamness GC, Benedix MG, Greene GL, O'Malley BW, McGuire WL. Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. Journal of the National Cancer Institute. 83: 1157-60. PMID 1679459 DOI: 10.1093/Jnci/83.16.1157  0.361
1990 Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer. 66: 1663-70. PMID 2208020 DOI: 10.1002/1097-0142(19901015)66:8<1663::Aid-Cncr2820660802>3.0.Co;2-C  0.386
1990 Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Molecular Endocrinology (Baltimore, Md.). 4: 1465-73. PMID 2178215 DOI: 10.1210/Mend-4-10-1465  0.411
1989 Klein-Hitpass L, Tsai SY, Greene GL, Clark JH, Tsai MJ, O'Malley BW. Specific binding of estrogen receptor to the estrogen response element. Molecular and Cellular Biology. 9: 43-9. PMID 2927397 DOI: 10.1128/Mcb.9.1.43  0.438
1989 Read LD, Greene GL, Katzenellenbogen BS. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molecular Endocrinology (Baltimore, Md.). 3: 295-304. PMID 2785242 DOI: 10.1210/Mend-3-2-295  0.39
1989 Berger U, Wilson P, Thethi S, McClelland RA, Greene GL, Coombes RC. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors. Cancer Research. 49: 5176-9. PMID 2766287  0.319
1989 Press MF, Xu SH, Wang JD, Greene GL. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. The American Journal of Pathology. 135: 857-64. PMID 2683797  0.307
1989 Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarty KS. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Research. 49: 1052-6. PMID 2643460  0.303
1989 Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Research. 49: 145-8. PMID 2562795  0.304
1989 DeRosa CM, Ozzello L, Habif DV, Konrath JG, Greene GL. Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas. Annals of Surgery. 210: 224-8. PMID 2547346 DOI: 10.1097/00000658-198908000-00015  0.417
1988 Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Molecular Endocrinology (Baltimore, Md.). 2: 263-71. PMID 3398853 DOI: 10.1210/Mend-2-3-263  0.398
1988 Waterman ML, Adler S, Nelson C, Greene GL, Evans RM, Rosenfeld MG. A single domain of the estrogen receptor confers deoxyribonucleic acid binding and transcriptional activation of the rat prolactin gene. Molecular Endocrinology (Baltimore, Md.). 2: 14-21. PMID 3398840 DOI: 10.1210/Mend-2-1-14  0.394
1988 Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology. 122: 935-44. PMID 3342760 DOI: 10.1210/Endo-122-3-935  0.397
1988 Pertschuk LP, Feldman JG, Eisenberg KB, Carter AC, Thelmo WL, Cruz WP, Thorpe SM, Christensen J, Rasmussen BB, Rose C, Greene GL. Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease-free survival, and clinical endocrine response Cancer. 62: 342-349. PMID 3289729 DOI: 10.1002/1097-0142(19880715)62:2<342::Aid-Cncr2820620219>3.0.Co;2-1  0.346
1988 West NB, Roselli CE, Resko JA, Greene GL, Brenner RM. Estrogen and progestin receptors and aromatase activity in rhesus monkey prostate. Endocrinology. 123: 2312-22. PMID 3262505 DOI: 10.1210/Endo-123-5-2312  0.361
1988 Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science (New York, N.Y.). 241: 81-4. PMID 3164526 DOI: 10.1126/Science.3164526  0.407
1988 Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. The Journal of Clinical Endocrinology and Metabolism. 67: 334-40. PMID 2455728 DOI: 10.1210/Jcem-67-2-334  0.397
1987 Rao KV, Peralta WD, Greene GL, Fox CF. Cellular progesterone receptor phosphorylation in response to ligands activating protein kinases. Biochemical and Biophysical Research Communications. 146: 1357-65. PMID 3497636 DOI: 10.1016/0006-291X(87)90799-6  0.377
1987 Law ML, Kao FT, Wei Q, Hartz JA, Greene GL, Zarucki-Schulz T, Conneely OM, Jones C, Puck TT, O'Malley BW. The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2. Proceedings of the National Academy of Sciences of the United States of America. 84: 2877-81. PMID 3472240 DOI: 10.1073/Pnas.84.9.2877  0.35
1987 Maxwell BL, McDonnell DP, Conneely OM, Schulz TZ, Greene GL, O'Malley BW. Structural organization and regulation of the chicken estrogen receptor. Molecular Endocrinology (Baltimore, Md.). 1: 25-35. PMID 2901032 DOI: 10.1210/Mend-1-1-25  0.361
1986 Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science (New York, N.Y.). 231: 1150-4. PMID 3753802 DOI: 10.1126/Science.3753802  0.425
1986 Greene GL, Press MF. Structure and dynamics of the estrogen receptor Journal of Steroid Biochemistry. 24: 1-7. PMID 3517497 DOI: 10.1016/0022-4731(86)90024-5  0.463
1986 Conneely OM, Sullivan WP, Toft DO, Birnbaumer M, Cook RG, Maxwell BL, Zarucki-Schulz T, Greene GL, Schrader WT, O'Malley BW. Molecular cloning of the chicken progesterone receptor. Science (New York, N.Y.). 233: 767-70. PMID 2426779 DOI: 10.1126/Science.2426779  0.362
1986 Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P. Cloning of the human oestrogen receptor cDNA Journal of Steroid Biochemistry. 24: 77-83. PMID 2422449 DOI: 10.1016/0022-4731(86)90035-X  0.351
1985 Lorincz MA, Holt JA, Greene GL. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. The Journal of Clinical Endocrinology and Metabolism. 61: 412-7. PMID 4019711 DOI: 10.1210/Jcem-61-3-412  0.425
1985 Miller MA, Mullick A, Greene GL, Katzenellenbogen BS. Characterization of the subunit nature of nuclear estrogen receptors by chemical cross-linking and dense amino acid labeling Endocrinology. 117: 515-522. PMID 4017945 DOI: 10.1210/Endo-117-2-515  0.378
1985 Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M. Cloning of the human estrogen receptor cDNA Proceedings of the National Academy of Sciences of the United States of America. 82: 7889-7893. PMID 3865204 DOI: 10.1073/Pnas.82.23.7889  0.354
1985 Poulsen HS, Ozzello L, King WJ, Greene GL. The use of monoclonal antibodies to estrogen receptors (ER) for immunoperoxidase detection of ER in paraffin sections of human breast cancer tissue Journal of Histochemistry and Cytochemistry. 33: 87-92. PMID 2578501 DOI: 10.1177/33.2.2578501  0.419
1985 Holt J, Gibson R, Hamilton T, Greene G, Herbst A. Estrogen receptor-rich ovarian adenocarcinoma in vitro and OVCAR-3 in vivo bind radio-halogenated moxestrol (R-2858) Gynecologic Oncology. 20: 255. DOI: 10.1016/0090-8258(85)90171-4  0.379
1984 Miller MA, Greene GL, Katzenellenbogen BS. Estrogen receptor transformation in MCF-7 breast cancer cells: Characterization by immunochemical and sedimentation analyses Endocrinology. 114: 296-298. PMID 6690275 DOI: 10.1210/Endo-114-1-296  0.374
1984 Kasid A, Strobl JS, Huff K, Greene GL, Lippman ME. A novel nuclear form of estradiol receptor in MCF-7 human breast cancer cells. Science (New York, N.Y.). 225: 1162-5. PMID 6474170 DOI: 10.1126/Science.6474170  0.44
1984 McClellan MC, West NB, Tacha DE, Greene GL, Brenner RM. Immunocytochemical localization of estrogen receptors in the macaque reproductive tract with monoclonal antiestrophilins. Endocrinology. 114: 2002-14. PMID 6373239 DOI: 10.1210/Endo-114-6-2002  0.359
1984 Greene GL, Sobel NB, King WJ, Jensen EV. Immunochemical studies of estrogen receptors. Journal of Steroid Biochemistry. 20: 51-6. PMID 6200700 DOI: 10.1016/0022-4731(84)90188-2  0.406
1983 Tate AC, DeSombre ER, Greene GL, Jensen EV, Jordan VC. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody. Breast Cancer Research and Treatment. 3: 267-77. PMID 6671136 DOI: 10.1007/Bf01806700  0.396
1983 Ekman P, Barrack ER, Greene GL, Jensen EV, Walsh PC. Estrogen receptors in human prostate: evidence for multiple binding sites. The Journal of Clinical Endocrinology and Metabolism. 57: 166-76. PMID 6189851 DOI: 10.1210/Jcem-57-1-166  0.384
1983 Holt J, Makii M, Greene G, Herbst A, Tate A, Jordan V. Monoclonal antibody recognition of [3H]monohydroxytamoxifen-receptor and 125I-estradiol-receptor complex in ovarian epithelial carcinoma Gynecologic Oncology. 15: 134. DOI: 10.1016/0090-8258(83)90129-4  0.343
1980 Greene GL, Fitch FW, Jensen EV. Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors. Proceedings of the National Academy of Sciences of the United States of America. 77: 157-61. PMID 6928610 DOI: 10.1073/Pnas.77.1.157  0.337
1975 Greene GL, Letsinger RL. Formation of internucleotide 3'-5' phosphoramidate links by direct coupling of phosphoryl and amino groups. Nucleic Acids Research. 2: 1123-7. PMID 1153331 DOI: 10.1093/Nar/2.7.1123  0.491
1975 Mungall WS, Greene GL, Heavner GA, Letsinger RL. Use of azido group in the synthesis of 5' terminal aminodeoxythymidine oligonucleotides. The Journal of Organic Chemistry. 40: 1569-62. PMID 1142038 DOI: 10.1021/Jo00899A038  0.491
1975 Mungall WS, Greene GL, Heavner GA, Letsinger RL. Use of the azido group in the synthesis of 5′ terminal aminodeoxythymidine oligonucleotides Journal of Organic Chemistry. 40: 1659-1662. DOI: 10.1002/Chin.197536407  0.493
1974 Mungall WS, Greene GL, Miller PS, Letsinger RL. Use of phosphorus oxychloride in synthesizing nucleotides and oligonucleotides. Nucleic Acids Research. 1: 615-27. PMID 10793743 DOI: 10.1093/Nar/1.4.615  0.597
Show low-probability matches.